Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation.

Dawid Leander StaudacherPaul M BieverChristoph BenkIngo AhrensChristoph BodeTobias Wengenmayer

Published in: PloS one (2016)

Bleeding on VA-ECMO is frequent. This registry recorded no statistical difference in bleeding in patients on dual antiplatelet therapy when compared to no antiplatelet therapy. When indicated, DAPT should not be withheld from VA ECMO patients.

Keyphrases

antiplatelet therapy
extracorporeal membrane oxygenation
acute coronary syndrome
percutaneous coronary intervention
end stage renal disease
acute respiratory distress syndrome
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
risk factors
patient reported outcomes
patient reported